From Uncertainty to Evidence

Biostatistics that transforms complexity into confident decisions

CLINICAL TRIALS | REAL-WORLD EVIDENCE | STATISTICAL INNOVATION

From Uncertainty to Evidence

Biostatistics that transforms complexity into confident decisions

CLINICAL TRIALS | REAL-WORLD EVIDENCE | STATISTICAL INNOVATION

From Uncertainty to Evidence

Biostatistics that transforms complexity into confident decisions

CLINICAL TRIALS | REAL-WORLD EVIDENCE | STATISTICAL INNOVATION

THE TRIAL ENDED

THE EVIDENCE JOURNEY DID NOT

Clinical trials tell us whether a treatment can work

But every patient entering a trial is only a tiny fraction of the patients we finally want to treat

Our mission is to transform clinical trial results into trustworthy evidence that supports better healthcare decisions.

Abstract image of colorful waves on a black background

Confidence without Certainty

Reports speak in conclusions.

Data speak in probabilities >

Legacy Trials as Latent Assets

Most studies answer one question The data often contain many more >

Abstract image of a colorful, wavy landscape with glowing particles and lines.

Multiplicity as a System Property

How many statistical worlds did we explore before arriving at this result? >

From Data Chaos to Regulatory Evidence

Regulators do not approve datasets. They approve evidence >

Microscopic view of a neuron with its dendrites and axon.

Subgroup Discover = Subgroup Truth

Not every signal is a treatment effect. Not every pattern is meaningful >

The Trial Ended. The Evidence Journey did not

Trials tell us whether a treatment works. RWE shows how it actually works >

Confidence without Certainty

Reports speak in conclusions.

Data speak in probabilities >

Multiplicity as a System Property

How many statistical worlds did we explore before arriving at this result? >

Subgroup Discover ≠ Subgroup Truth

Not every signal is a treatment effect. Not every pattern is meaningful >

Legacy Trials as Latent Assets

Most studies answer one question The data often contain many more >

Regulators do not approve datasets. They approve evidence >

The Evidence Journey has Just Started

Trials tell us whether a treatment works. RWE shows how it actually works >

Confidence without Certainty

Reports speak in conclusions.

Data speak in probabilities >

Subgroup Discover = Subgroup Truth

Not every signal is a treatment effect. Not every pattern is meaningful >

From Data Chaos to Regulatory Evidence

Regulators do not approve datasets. They approve evidence >

Multiplicity as a System Property

How many statistical worlds did we explore before arriving at this result? >

Legacy Trials as Latent Assets

Most studies answer one question The data often contain many more >

The Trial Ended. The Evidence Journey did not

Trials tell us whether a treatment works. RWE shows how it actually works >

Building reliable evidence requires more than a single statistical analysis.

Better evidence is built step by step.

Trial Design

Good evidence starts before the first patient is enrolled.

We support study teams in translating scientific questions into measurable objectives, endpoints, estimands and statistical assumptions that will ultimately support reliable evidence generation.

Trial Design

Good evidence starts before the first patient is enrolled.

We support study teams in translating scientific questions into measurable objectives, endpoints, estimands and statistical assumptions that will ultimately support reliable evidence generation.

Ideas become valuable only when they improve real projects.

Legacy Trials

Multiplicity

Real-World Evidence

Legacy Trials

It is a renewable evidence asset.

A completed trial is not an archive.

Meta-analytic shrinkage

Subgroup discovery

External evidence integration

AI-assisted exploration

Scientific expertise alone is not enough. Successful collaboration also requires transparent workflows and long-term partnership.

Why sponsors choose Planimeter

Instead of generic analytics, we combine statistical expertise, modern computational methods and reproducible workflows to deliver evidence you can trust.

Scientific Rigor

✔ Clinical trial statistics

✔ Advanced modelling

✔ Regulatory thinking

Modern Evidence

✔ Real-World Evidence

✔ Legacy trial integration

✔ Multiplicity & subgroup analytics

Reproducible workflows

✔ SAS

✔ R

✔ CDISC

✔ Automated reporting

Collaborative delivery

✔ Direct communication

✔ Transparent timelines

✔ Long-term partnerships

Get to Know Us

Close to 30 years of history in the language of the numbers

From Uncertainty to Evidence

Biostatistics that transforms complexity into confident decisions

CLINICAL TRIALS | REAL-WORLD EVIDENCE | STATISTICAL INNOVATION

From Uncertainty to Evidence

Biostatistics that transforms complexity into confident decisions

CLINICAL TRIALS | REAL-WORLD EVIDENCE | STATISTICAL INNOVATION

From Uncertainty to Evidence

Biostatistics that transforms complexity into confident decisions

CLINICAL TRIALS | REAL-WORLD EVIDENCE | STATISTICAL INNOVATION

THE TRIAL ENDED

THE TRIAL ENDED

THE TRIAL ENDED

THE EVIDENCE JOURNEY DID NOT

THE EVIDENCE JOURNEY DID NOT

THE EVIDENCE JOURNEY DID NOT

Building reliable evidence requires more than a single statistical analysis.

Building reliable evidence requires more than a single statistical analysis.

Better evidence is built step by step.

Ideas become valuable only when they improve real projects.

Scientific expertise alone is not enough. Successful collaboration also requires transparent workflows and long-term partnership.

Why sponsors choose Planimeter

Years of experience

Countries

Pharma Clients

Clinical Projects